Medistim ASA Total Liabilities
Medistim ASA total liabilities. Based on the latest financial reports, Medistim ASA (MEDI) has total liabilities worth Nkr151.23 Million NOK (≈ $15.91 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Medistim ASA (MEDI) liquidity interval to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Medistim ASA (2004–2024)
Total liabilities of Medistim ASA from 2004 to 2024. This chart illustrates how Medistim ASA's total liabilities have evolved over time, based on quarterly financial data. Check MEDI asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Medistim ASA Competitors by Total Liabilities
The table below lists competitors of Medistim ASA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhejiang Jasan Holding Group Co Ltd
SHG:603558
|
China | CN¥1.57 Billion |
|
Ares Acquisition Corporation II
NYSE:AACT
|
USA | $27.00 Million |
|
Ningbo Techmation Co Ltd
SHG:603015
|
China | CN¥653.36 Million |
|
Jiangsu Chuanzhiboke Education Tech
SHE:003032
|
China | CN¥1.05 Billion |
|
ShaoYang Victor Hydraulics Co.Ltd
SHE:301079
|
China | CN¥392.60 Million |
|
Nuh Cimento Sanayi AS
IS:NUHCM
|
Turkey | TL5.37 Billion |
|
Anshan Hifichem Co Ltd
SHE:300758
|
China | CN¥2.05 Billion |
|
ADENTRA INC.
F:UQ0
|
Germany | €808.36 Million |
Liability Composition Analysis (2004–2024)
This chart breaks down Medistim ASA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see MEDI asset base.
Liquidity & Leverage Metrics
Medistim ASA Total Liabilities Ratios Explained
Medistim ASA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.14 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medistim ASA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medistim ASA (2004–2024)
The table below shows the annual total liabilities of Medistim ASA from 2004 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Nkr138.36 Million ≈ $14.56 Million |
+28.37% |
| 2023-12-31 | Nkr107.78 Million ≈ $11.34 Million |
-6.25% |
| 2022-12-31 | Nkr114.97 Million ≈ $12.10 Million |
+18.29% |
| 2021-12-31 | Nkr97.19 Million ≈ $10.23 Million |
+9.24% |
| 2020-12-31 | Nkr88.97 Million ≈ $9.36 Million |
-10.35% |
| 2019-12-31 | Nkr99.25 Million ≈ $10.44 Million |
+57.84% |
| 2018-12-31 | Nkr62.88 Million ≈ $6.62 Million |
-7.64% |
| 2017-12-31 | Nkr68.08 Million ≈ $7.16 Million |
+35.23% |
| 2016-12-31 | Nkr50.34 Million ≈ $5.30 Million |
-19.15% |
| 2015-12-31 | Nkr62.27 Million ≈ $6.55 Million |
-3.29% |
| 2014-12-31 | Nkr64.39 Million ≈ $6.78 Million |
+37.72% |
| 2013-12-31 | Nkr46.76 Million ≈ $4.92 Million |
+27.41% |
| 2012-12-31 | Nkr36.70 Million ≈ $3.86 Million |
-14.14% |
| 2011-12-31 | Nkr42.74 Million ≈ $4.50 Million |
+12.15% |
| 2010-12-31 | Nkr38.11 Million ≈ $4.01 Million |
-3.11% |
| 2009-12-31 | Nkr39.33 Million ≈ $4.14 Million |
-21.21% |
| 2008-12-31 | Nkr49.92 Million ≈ $5.25 Million |
+42.82% |
| 2007-12-31 | Nkr34.96 Million ≈ $3.68 Million |
-22.47% |
| 2006-12-31 | Nkr45.09 Million ≈ $4.74 Million |
+156.44% |
| 2005-12-31 | Nkr17.58 Million ≈ $1.85 Million |
+40.95% |
| 2004-12-31 | Nkr12.47 Million ≈ $1.31 Million |
-- |
About Medistim ASA
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in… Read more